Myelofibrosis with Myeloid Metaplasia
Author:
- J BenbassatJBJ Benbassat
- 31 August 2000
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 343 (9) , 659-660
Abstract
We would like to report additional data concerning the results of allogeneic stem-cell transplantation for myelofibrosis with myeloid metaplasia, which were recently summarized by Tefferi (April 27 issue).1 Since our initial report,2 we have collected data on 11 new patients and have obtained further follow-up information on the original 55 patients. In an analysis of the overall group of 66 patients, the neutrophil-recovery rate remains high, rising to 84 percent by day 30. In a multivariate analysis, factors that remain associated with delayed engraftment are a low dose of nucleated cells, the absence of a pretransplantation splenectomy, and osteomyelosclerosis. We now find, in addition, that a pretransplantation hemoglobin level of less than 10 g per deciliter is associated with delayed neutrophil engraftment (P=0.043), a finding that may explain why patients with severe anemia have a worse outcome. With regard to acute graft-versus-host disease, we confirm that osteomyelosclerosis is a risk factor for grade III or IV acute graft-versus-host disease (incidence, 40 percent vs. 13 percent; P=0.027). In addition, this analysis shows that total-body irradiation is associated with grade II to IV acute graft-versus-host disease. Finally, a new multivariate analysis shows the influence of the recipient's age on five-year overall survival (14 percent for patients ≥45 years old vs. 62 percent for those 3,4 who are less than 40 years old, for whom planning a transplantation after the age of 45 years may not be the optimal strategy.Keywords
This publication has 8 references indexed in Scilit:
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patientsBlood, 2000
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]Blood, 1996
- The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasiaAmerican Journal of Hematology, 1990
- Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 casesArchives of internal medicine (1960), 1988
- THE NATURAL HISTORY OF AGNOGENIC MYELOID METAPLASIA (AMM) AND A CRITICAL EVALUATION OF ITS RELATIONSHIP WITH THE MYELOPROLIFERATIVE SYNDROMEMedicine, 1971
- Splenectomy for Hematologic DisordersArchives of Surgery, 1970